Generation of a polyclonal antibody against lipid peroxide-modified proteins

Free Radical Biology and Medicine

Volumn 23, Issue 2, 1997, Pages 251-259

  Kim, Jong G ^a   Sabbagh, Fadi ^a   Santanam, Nalini ^a   Wilcox, Josiah N ^a   Medford, Russell M ^a   Parthasarathy, Sampath ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aldehydes; Atherosclerosis; Lipid peroxidation; Low density lipoprotein; Oxidized low density lipoprotein

Indexed keywords

LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYCLONAL ANTIBODY; SERUM ALBUMIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION;

ALDEHYDES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; AORTA, ABDOMINAL; ARTERIOSCLEROSIS; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDES; MACACA FASCICULARIS; MALE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDES; PROTEINS; RABBITS; SERUM ALBUMIN;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030991952     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00615-6     Document Type: Article

References (29)

1. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
2. Parthasarathy S. Modified lipoproteins in the pathogenesis of atherosclerosis. 1994;R.G. Landes Company, Austin.
3. Penn M. S., Chisolm G. M. III. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis. 108 Suppl:1994;S21-S29.
4. Forrester J. S., Merz C. N., Bush T. L., Cohn J. N., Hunninghake D. B., Parthasarathy S., Superko H. R. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 4. Efficacy of risk factor management. J. Am. Coll. Cardiol. 27:1996;991-1006.
5. Esterbauer H., Jurgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28:1987;495-509.
6. Steinbrecher U. P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262:1987;3603-3608.
7. Shechter I., Fogelman A. M., Haberland M. E., Seager J., Hokom M., Edwards P. A. The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages. J. Lipid Res. 22:1981;63-71.
8. Haberland M. E., Fong D., Cheng L. Malondialdehyde-altered protein occurs in the atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241:1988;215-218.
9. Jurgens G., Ashy A., Esterbauer H. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein. Biochemical J. 265:1990;605-608.
10. Palinski W., Rosenfeld M. E., Ylä Herttuala S., Gurtner G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., Witztum J. L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
11. Fletcher B. L., Tappel A. L. Fluorescent modification of serum albumin by lipid peroxidation. Lipids. 6:1971;172-175.
12. Fong L. G., Parthasarathy S., Witztum J. L., Steinberg D. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J. Lipid Res. 28:1987;1466-1477.
13. Davies K. J. Protein modification by oxidants and the role of proteolytic enzymes. Biochem. Soc. Trans. 21:1993;346-353.
14. Stadtman E. R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 62:1993;797-821.
15. Levine R. L., Williams J. A., Stadtman E. R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233:1994;346-357.
16. Heinecke J. W., Li W., Francis G. A., Goldstein G. A. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91:1993;2866-2872.
17. Uchida K., Toyokuni S., Nishikawa K., Kawakishi S., Oda H., Hiai H., Stadtman E. R. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochem. 33:1994;12487-12494.
18. Uchida K., Stadtman E. R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA. 89:1992;4544-4548.
19. Fruebis J., Parthasarathy S., Steinberg D. Evidence for a concerted reaction between lipid hydroperoxides and polypeptides. Proc. Natl. Acad. Sci. USA. 89:1992;10588-10592.
20. Parthasarathy S. Lipid peroxidation-induced protein modifications in the oxidation of low density lipoprotein. Packer L., Cadenas E. Biological oxidants and antioxidants. 1994;255-259 Hippokrates Verlag, Stuttgart.
21. Bligh E. G., Dyer W. J. Rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
22. Santanam N., Parthasarathy S. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J. Clin. Invest. 95:1995;2594-2600.
23. Parthasarathy S., Fong L. G., Otero D., Steinberg D. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc. Natl. Acad. Sci. USA. 84:1987;537-540.
24. Steinbrecher U. P., Witztum J. L., Parthasarathy S., Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7:1987;135-143.
25. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
26. Houglum K., Filip M., Witztum J. L., Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J. Clin. Invest. 86:1990;1991-1998.
27. Rosenfeld M. E., Palinski W., Yla Herttuala S., Butler S., Witztum J. L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1990;336-349.
28. Staprans I., Pan X. M., Miller M., Rapp J. H. Effect of dietary lipid peroxides on metabolism of serum chylomicrons in rats. Am. J. Physiol. 264:1993;G561-8.
29. Staprans I., Rapp J. H., Pan X. M., Feingold K. R. The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats. J. Clin. Invest. 92:1993;638-643.